Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CD55 anticorps

Cet anticorps anti-CD55 est un anticorps Souris Monoclonal détectant CD55 dans ICFC. Adapté pour Humain.
N° du produit ABIN2664770

Aperçu rapide pour CD55 anticorps (ABIN2664770)

Antigène

Voir toutes CD55 Anticorps
CD55 (Complement Decay-Accelerating Factor (CD55))

Reactivité

  • 139
  • 33
  • 7
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
Humain

Hôte

  • 92
  • 73
  • 6
  • 5
  • 3
  • 1
  • 1
  • 1
Souris

Clonalité

  • 120
  • 60
  • 2
Monoclonal

Conjugué

  • 80
  • 18
  • 17
  • 12
  • 6
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CD55 est non-conjugé

Application

  • 102
  • 99
  • 46
  • 40
  • 35
  • 23
  • 17
  • 15
  • 14
  • 14
  • 14
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Intracellular Flow Cytometry (ICFC)

Clone

JS11
  • Purification

    The antibody was purified by affinity chromatography.

    Isotype

    IgG1 kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.5 mg/mL

    Buffer

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • Antigène

    CD55 (Complement Decay-Accelerating Factor (CD55))

    Autre désignation

    CD55

    Sujet

    CD55 is a 60-70 kD glycosylphosphatidylinositol (GPI)-anchored single chain glycoprotein also known as decay-accelerating factor (DAF). It is expressed on hematopoietic cells including erythrocytes and many non-hematopoietic cells. CD55 accelerates the dissociation of the components of the C3-convertases (namely C2a from C4b in the C4bC2a complex, a C3-convertase of the classical pathway, and factor Bb from the C3bBb complex, a C3-convertase of the alternative pathway) to protect cells from inappropriate damage caused by autologous complement. CD55 has been reported to reduce the efficiency of NK cell lysis and induce signal transduction in T cells. CD55 has also been shown to interact with CD97 and bind to Coxsackie and Echovirus.

    Pathways

    Système du Complément, Regulation of Leukocyte Mediated Immunity
Vous êtes ici:
Chat with us!